|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMBRYONIC STEM CELLS |
1 Developmental Biology Laboratory, Biomedical Research Foundation of the Academy of Athens, Athens 11527, Greece
2 Mammalian Neurogenesis Group, MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, Du Cane Rd., London W12 0NN
* To whom correspondence should be addressed. E-mail: agavalas{at}bioacademy.gr.
| Abstract |
|---|
The delineation of regulatory networks involved in early endocrine pancreas specification will play a crucial role in directing the differentiation of embryonic stem cells towards the mature phenotype of
cells for cell therapy of Type I diabetes. The transcription factor ngn3 is required for the specification of the endocrine lineage but direct targets and the scope of biological processes it regulates remain elusive. We show that stepwise differentiation of embryonic stem cells using successive in vivo patterning signals can lead to simultaneous induction of Ptf1a and Pdx1 expression. In this cellular context, ngn3 induction results in up-regulation of its known direct target genes within twelve hours. Microarray gene expression profiling at distinct time points following ngn3 induction suggested novel and diverse roles of ngn3 in pancreas endocrine cell specification. Induction of ngn3 expression results in regulation of the Wnt, integrin, Notch and TGF
signalling pathways and changes in biological processes affecting cell motility, adhesion, the cytoskeleton, the extracellular matrix and gene expression. Furthermore, the combination of in vivo patterning signals and inducible ngn3 expression enhance ESC differentiation towards the pancreas endocrine lineage. This is shown by strong upregulation of endocrine lineage terminal differentiation markers and strong expression of the hormones glucagon, somatostatin and insulin. Importantly, all insulin+ cells are also C-peptide+ and glucose-dependent insulin release was 10-fold higher than basal levels. These data suggest that bona fide pancreas endocrine cells have been generated and that timely induction of ngn3 expression can play a decisive role in directing ESC differentiation towards the endocrine lineage.
This article has been cited by other articles:
![]() |
M Mimeault and S K Batra Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer Gut, October 1, 2008; 57(10): 1456 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gouti and A. Gavalas Hoxb1 Controls Cell Fate Specification and Proliferative Capacity of Neural Stem and Progenitor Cells Stem Cells, August 1, 2008; 26(8): 1985 - 1997. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
